1-17 of 17
Paolo Neviani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A026 Cellular and zebrafish models for DICER1 related tumour predisposition (DRTP)

Mona K. Wu, Paolo Neviani, James F. Amatruda
Journal: Cancer Research
Cancer Res (2024) 84 (17_Supplement): A026.
https://doi.org/10.1158/1538-7445.PEDIATRIC24-A026
Published: 05 September 2024
View article titled, Abstract A026 Cellular and zebrafish models for DICER1 related tumour predisposition (DRTP)
Journal Articles

Abstract 3633: Multi-parametric characterization of extracellular vesicles in the aqueous humor of uveal melanoma eyes undergoing brachytherapy

Shreya Sirivolu, Chen-Ching Peng, Paolo Neviani, Jesse L. Berry, Liya Xu
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3633.
https://doi.org/10.1158/1538-7445.AM2024-3633
Published: 22 March 2024
View article titled, Abstract 3633: Multi-parametric characterization of extracellular vesicles in the aqueous humor of uveal melanoma eyes undergoing brachytherapy
Journal Articles

Abstract 6717: Extracellular vesicles in diagnostic retinoblastoma aqueous humor correlate with disease stage and clinical outcome: a pilot study

Sarah Pike, Chen-Ching Peng, Paolo Neviani, Jesse L. Berry, Liya Xu
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6717.
https://doi.org/10.1158/1538-7445.AM2023-6717
Published: 04 April 2023
View article titled, Abstract 6717: Extracellular vesicles in diagnostic retinoblastoma aqueous humor correlate with disease stage and clinical outcome: a pilot study
Journal Articles

Abstract 3416: Clearance of tumor-derived extracellular vesicle heterogeneity in aqueous humor after chemotherapy in retinoblastoma eyes

Chen-Ching Peng, Deborah Im, Shreya Sirivolu, Bibiana Reiser, Aaron Nagiel, Paolo Neviani, Liya Xu, Jesse L. Berry
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3416.
https://doi.org/10.1158/1538-7445.AM2022-3416
Published: 15 June 2022
View article titled, Abstract 3416: Clearance of tumor-derived extracellular vesicle heterogeneity in aqueous humor after chemotherapy in retinoblastoma eyes
Journal Articles

Abstract 2504: Next generation sequencing identifies novel potential biomarkers for DICER1 syndrome

Mona K. Wu, Raphael D. Lopez, Mikako Warren, Rachana Shah, Paolo Neviani, James F. Amatruda
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2504.
https://doi.org/10.1158/1538-7445.AM2022-2504
Published: 15 June 2022
View article titled, Abstract 2504: Next generation sequencing identifies novel potential biomarkers for DICER1 syndrome
Journal Articles

Natural Killer–Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms

Paolo Neviani, Petra M. Wise, Mariam Murtadha, Cathy W. Liu, Chun-Hua Wu, Ambrose Y. Jong, Robert C. Seeger, Muller Fabbri
Journal: Cancer Research
Cancer Res (2019) 79 (6): 1151–1164.
https://doi.org/10.1158/0008-5472.CAN-18-0779
Published: 15 March 2019
View article titled, Natural Killer–Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms
Open the PDF for Natural Killer–Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms in another window
Includes: Supplementary data
Journal Articles

Abstract 1134: The tumor suppressor activity of miR-300 is detrimental for leukemia development but required for leukemia stem cell maintenance

Giovannino Silvestri, Lorenzo Stramucci, Justin Ellis, Jason Harb, Paolo Neviani, Bin Zhang, Klara Srutova, Gabriel Pineda, Catriona Jamieson, Bruno Calabretta, Fabio Stagno, Paolo Vigneri, Georgios Nteliopoulos, Philippa May, Alistar Reid, Ramiro Garzon, Denis-Claude Roy, Martin Guimond, Peter Hokland, Michael Deininger, Garrett Fitzgerald, Chris Harman, Francesco Dazzi, Dragana Milojkovic, Jane Apperley, Guido Marcucci, Jianfei Qi, Katerina Machova-Polakova, Xiaoxuan Fan, Maria Baer, Rossana Trotta, Danilo Perrotti
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1134.
https://doi.org/10.1158/1538-7445.AM2018-1134
Published: 01 July 2018
View article titled, Abstract 1134: The tumor suppressor activity of miR-300 is detrimental for leukemia development but required for leukemia stem cell maintenance
Journal Articles

Abstract 951: Role of the MSC-derived exosomal and endogenous JAK2-SET/PP2A-β-catenin-modulator miR-300 in leukemic stem/progenitor proliferation and survival in CML

Rossana Trotta, Giovannino Silvestri, Lorenzo Stramucci, Justin J. Ellis, Justine Yu, Jason J. Harb, Paolo Neviani, Guido Marcucci, Klara Srutova, Polakova K. Machova, Denis-Claude Roy, Peter Hokland, Michael Deininger, Ravi Bhatia, Carlo Gambacorti-Passerini, Dragana Milojkovic, Alistair Reid, Jane Apperley, Ferenc Livak, Jianfei Qi, Maria R. Baer, Danilo Perrotti
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 951.
https://doi.org/10.1158/1538-7445.AM2016-951
Published: 15 July 2016
View article titled, Abstract 951: Role of the MSC-derived exosomal and endogenous JAK2-SET/PP2A-β-catenin-modulator miR-300 in leukemic stem/progenitor proliferation and survival in CML
Journal Articles

Abstract 3454: Bcl-xL anti-apoptotic network is dispensable for emergence and maintenance of CML but required for disease progression, and represents an alternative target for halting survival of blast crisis CML progenitors.

Jason Harb, Paolo Neviani, Justin E. Ellis, Gregory J. Ferenchak, Brenda I. Chyla, Peter Hokland, Denis Claude Roy, Michael A. Caligiuri, Guido Marcucci, Claudia S. Huettner, Danilo Perrotti
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3454.
https://doi.org/10.1158/1538-7445.AM2013-3454
Published: 15 April 2013
View article titled, Abstract 3454: Bcl-xL anti-apoptotic network is dispensable for emergence and maintenance of CML but required for disease progression, and represents an alternative target for halting survival of blast crisis CML progenitors.
Journal Articles

Abstract 3839: Nuclear export (karyopherin) inhibitors: A novel therapeutic strategy for treating Philadelphia-positive (Ph+) acute leukemias

Christopher Walker, Joshua J. Oaks, Ramasamy Santhanam, Paolo Neviani, Jason G. Harb, Carolyn Paisie, Guido Marcucci, Yosef Landesman, Sharon Shacham, Michael Kauffman, Danilo Perrotti
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3839.
https://doi.org/10.1158/1538-7445.AM2012-3839
Published: 15 April 2012
View article titled, Abstract 3839: Nuclear export (karyopherin) inhibitors: A novel therapeutic strategy for treating Philadelphia-positive (Ph<sup>+</sup>) acute leukemias
Journal Articles

Abstract LB-109: BCR-ABL1 kinase activity but not its expression is dispensable for Ph+ quiescent stem cell survival which depends on the PP2A-controlled Jak2 activation and is sensitive to FTY720 treatment

Paolo Neviani, Jason Harb, Joshua Oaks, Christopher Walker, Ramasamy Santhanam, Carolyn Paisie, Anna Eiring, Bin Zhang, Bastianella Perazzona, Y Ma, Charlene Mao, Guido Marcucci, Tessa Holyoake, Stefano Volinia, Jorge Cortes, Michael Caligiuri, Claudia Huettner, Robert Bittman, Ching-Shih Chen, Ralph Arlinghaus, Peter Hokland, Denis-Claude Roy, Ravi Bhatia, Danilo Perrotti
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): LB-109.
https://doi.org/10.1158/1538-7445.AM2011-LB-109
Published: 15 April 2011
View article titled, Abstract LB-109: BCR-ABL1 kinase activity but not its expression is dispensable for Ph+ quiescent stem cell survival which depends on the PP2A-controlled Jak2 activation and is sensitive to FTY720 treatment
Journal Articles

Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers

Kathryn G. Roberts, Amanda M. Smith, Fiona McDougall, Helen Carpenter, Martin Horan, Paolo Neviani, Jason A. Powell, Daniel Thomas, Mark A. Guthridge, Danilo Perrotti, Alistair T.R. Sim, Leonie K. Ashman, Nicole M. Verrills
Journal: Cancer Research
Cancer Res (2010) 70 (13): 5438–5447.
https://doi.org/10.1158/0008-5472.CAN-09-2544
Published: 30 June 2010
View article titled, Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT<sup>+</sup> Cancers
Open the PDF for Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT<sup>+</sup> Cancers in another window
Includes: Supplementary data
Journal Articles

Abstract 1950: Suppression of RISC-independent decoy and RISC-mediated RNA-pairing activities of microRNA-328 is required for maturation-arrest and enhanced survival of blast crisis CML progenitors

Anna M. Eiring, Jason Harb, Paolo Neviani, Joshua J. Oaks, Shujun Liu, Riccardo Spizzo, Sebastian Schwind, Ramasamy Santhanam, Christopher Hickey, Heiko Becker, Jason C. Chandler, Raul Andino, Jorge Cortes, Peter Hokland, Claudia S. Huettner, Ravi Bhatia, Denis C. Roy, Stephen Liebhaber, Michael A. Caligiuri, Guido Marcucci, Ramiro Garzon, Carlo M. Croce, George A. Calin, Danilo Perrotti
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1950.
https://doi.org/10.1158/1538-7445.AM10-1950
Published: 15 April 2010
View article titled, Abstract 1950: Suppression of RISC-independent decoy and RISC-mediated RNA-pairing activities of microRNA-328 is required for maturation-arrest and enhanced survival of blast crisis CML progenitors
Journal Articles

Abstract #1075: PP2A induction by FTY720 inhibits survival and self-renewal of CD34+/CD38- CML stem cell through the simultaneous suppression of BCR/ABL and BCR/ABL-independent signals.

Paolo Neviani, Ramasamy Santhanam, Yihui Ma, Bin Zhang, Hsiaoyin Mao, Stefano Volinia, Guido Marcucci, Ching-Shih Chen, Jorge Cortes, Claudia Huettner, Steffen Koschmieder, Peter Hokland, Ravi Bhatia, Denis Roy, Michael Caligiuri, Danilo Perrotti
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1075.
Published: 01 May 2009
View article titled, Abstract #1075: PP2A induction by FTY720 inhibits survival and self-renewal of CD34+/CD38- CML stem cell through the simultaneous suppression of BCR/ABL and BCR/ABL-independent signals.
Journal Articles

MicroRNAs act as decoy molecules to restore granulocytic maturation of differentiation-arrested BCR/ABL+ myeloid progenitors

Anna Eiring, Paolo Neviani, George Calin, Denis Roy, Carlo Croce, Danilo Perrotti
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 1494.
Published: 01 May 2008
View article titled, MicroRNAs act as decoy molecules to restore granulocytic maturation of differentiation-arrested BCR/ABL<sup>+</sup> myeloid progenitors
Journal Articles

FTY720, a new and alternative strategy for treating blast crisis CML and Ph1 ALL patients

Paolo Neviani, Ramasamy Santhanam, Joshua Oaks, Anna Eiring, Mario Notari, Bradley Blaser, Shujun Liu, Rossana Trotta, Natarajan Muthusamy, Carlo Gambacorti-Passerini, Brian Druker, Jorge Cortes, Guido Marcucci, Ching-Shih Chen, Denis Roy, Michael Caligiuri, Clara Bloomfield, John Byrd, Danilo Perrotti
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1638.
Published: 01 May 2007
View article titled, FTY720, a new and alternative strategy for treating blast crisis CML and Ph<sup>1 </sup>ALL patients
Journal Articles

Activation of PP2A: A novel mechanism for a potential targeted therapy of blast crisis and imatinib-resistant chronic myelogenous leukemia

Paolo Neviani, Ramasamy Santhanam, Rossana Trotta, Mario Notari, Ashwin Uttam, Bradley W. Blaser, Shujun Liu, Denis C. Roy, Michael A. Caligiuri, Clara D. Bloomfield, Guido Marcucci, Danilo Perrotti
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 358.
Published: 01 May 2005
View article titled, Activation of PP2A: A novel mechanism for a potential targeted therapy of blast crisis and imatinib-resistant chronic myelogenous leukemia